IP Library Granted Patent US 10,227,285
Granted Patent B2
US 10,227,285 · App. 14/942,765 · Granted Mar 12, 2019

Processes and intermediates for preparing alpha,omega-dicarboxylic acid-terminated dialkane ethers

Inventors: Carmen Daniela Oniciu (Toulouse, FR); Otto Joseph Geoffroy (Gainesville, FL)
Assignee: GEMPHIRE THERAPEUTICS INC.
C07C67/31C07C51/09C07C51/412C07C51/43C07C67/307C07C67/343C07D309/12C07D313/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,227,285
App. No.
14/942,765
Granted
Mar 12, 2019
Kind
B2
Abstract

The present disclosure provides a process for the preparation of compounds of formula (III), compounds of formula (V), and corresponding salts of formula (IV). The compounds made by the methods and processes of the invention are particularly useful for administration in humans and animals.

Claims (35)

1. A process for making crude compound (2):

comprising:

(a) allowing ethyl isobutyrate to react with lithium diisopropylamide at a first temperature ranging from approximately −78° C. to approximately −10° C. to provide a lithium enolate of ethyl isobutyrate;

(b) allowing the lithium enolate of ethyl isobutyrate to react with compound (1)

at a second temperature ranging from approximately −20° C. to 0° C. to provide a reaction mixture; and

(c) subjecting the reaction mixture to an aqueous work-up with organic solvent extraction to provide crude compound (2),

wherein steps (a) and (b) are performed in the absence of DMSO or a chelating additive and wherein the crude compound (2) is not further purified.

2. A process for making compound (3)

comprising:

(a) performing the process of claim 1 ;

(b) hydrolyzing the crude compound (2) with an alkali metal base; and

(c) acidifying the product of step (b) to provide compound (3).

3. The process of claim 2 , wherein the alkali metal base is potassium hydroxide.

4. A process for making compound (4)

comprising:

performing the process of claim 2 and

allowing compound (3) to react with CaO to provide compound (4).

5. The process of claim 4 , wherein compound (3) reacts with CaO in absolute ethanol at reflux and provides compound (4) in an ethanolic mixture.

6. The process of claim 5 , further comprising the steps of:

allowing the ethanolic mixture to cool to room temperature;

diluting the ethanolic mixture with methyl t-butyl ether to provide an ethanol-and-methyl t-butyl ether mixture;

allowing compound (4) to precipitate from the ethanol-and-methyl t-butyl ether mixture; and

filtering compound (4) from the ethanol-and-methyl t-butyl ether mixture to provide a filtered compound (4).

7. A process for making a hydrate of compound (4), comprising:

performing the process of claim 6 ;

drying the filtered compound (4); and

hydrating the filtered compound (4) to provide the hydrate of compound (4).

8. The process of claim 7 , wherein the hydrating is performed at 100° C.

9. The process of claim 1 , wherein the lithium diisopropylamide is generated from diisopropylamine and n-hexyllithium.

10. The process of claim 1 , wherein the second temperature is approximately −20° C.

11. The process of claim 1 , wherein the second temperature is 0° C.

12. The process of claim 1 , wherein crude compound (2) is made on a scale larger than 1 kg.

13. The process of claim 1 , further comprising allowing crude compound (2)

to react with an aqueous solution of CaO or Ca(OH) 2 in water-miscible solvent to provide compound (4)

14. The process of claim 13 , wherein the water-miscible solvent is DMF, DMSO, acetone, methanol, ethanol or isopropyl alcohol.

Assignments (5)
CHANGE OF NAME Recorded Mar 16, 2020
From: GEMPHIRE THERAPEUTICS INC.
To: NEUROBO PHARMACEUTICALS, INC.
Reel/Frame 052180/0336 →
CHANGE OF ADDRESS FOR ASSIGNEE Recorded Nov 19, 2019
From: GEMPHIRE THERAPEUTICS INC.
To: GEMPHIRE THERAPEUTICS INC.
Reel/Frame 051058/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2016
From: ONICIU, CARMEN DANIELA
To: GEMPHIRE THERAPEUTICS INC.
Reel/Frame 037466/0681 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2016
From: GEOFFROY, OTTO JOSEPH
To: ALCHEM LABORATORIES CORPORATION
Reel/Frame 037467/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2016
From: ALCHEM LABORATORIES CORPORATION
To: GEMPHIRE THERAPEUTICS INC.
Reel/Frame 037467/0292 →
Continuity (3)
Provisional Application 62079894 · Nov 14, 2014
Related Publication 20160137584A1 · May 19, 2016
Related Publication 20170158601A9 · Jun 8, 2017
Cited By (1)
US 12,503,422